The Daily Hit: August 14, 2023
The Daily Hit is a recap of the top financial news stories for Aug. 14,
Urban-Gro Losses Stable While Revenues Continue Down from 2022
The company said it is “laser-focused” on identifying additional efficiencies. Colorado-based Urban-Gro (Nasdaq: UGRO) this
Goodness Growth in Line with Expectations in Q2, Will Divest in NY
Management said investors can expect more clarity more clarity on the New York divestiture in
Harmony Biosciences Buys Zynerba Pharmaceuticals in $60M Deal
Harmony will fund the transaction from its existing cash on hand. Harmony Biosciences Holdings Inc.
Safe Harbor Losses Mount Despite Skyrocketing Revenue
SHF Holdings Inc. (Nasdaq: SHFS), which operates as Safe Harbor Financial, saw its revenue shoot
Tilt Revenue Falls as Focus Turns to Jupiter
Tilt Holdings Inc. (Cboe: TILT) (OTCQX: TLLTF) reported revenue fell to $41.6 million for the three months
Number of the Week: 23%
23% – Percentage of U.S. consumers that use concentrates Nearly a quarter of cannabis consumers
Predictions for Future Federal Cannabis Laws
By Griffen Thorne, Attorney at Harris Bricken Most Americans favor federal cannabis legalization. Nearly all Americans support medical
Enveric Biosciences Loses $6.4 Million in Q2, Announces Cost-Reduction Plan
The company said it progressed toward obtaining federal patents on synthetic psychedelic drugs. Florida-based Enveric
Cybin Inches Closer to FDA Submission, Increases Losses in Q1
Toronto-based Cybin Inc. (NYSE: CYBN) (NEO: CYBN) increased its losses for its first fiscal quarter